Stevanato Group, a producer of glass primary packaging and capabilities for drug delivery systems, has expanded its longstanding collaboration with Catalent to include the provision and accelerated delivery of advanced visual inspection systems to help with potential vaccines and biologics to address the pandemic.

Stevanato’s integrated capabilities and visual inspection machines will be used to support Catalent and its customers’ biologics and sterile injectable products.

Catalent has ordered Plus 400 LKD automatic and PWL semi-automatic visual inspection machines from Stevanato and will install the equipment at its sites in Bloomington, IN, and Anagni, Italy, to support various customer programs. The quality assurance solutions feature advanced technologies to reliably inspect biologics and sterile injectables, maximizing the detection rate while keeping false rejects low. Stevanato is accelerating delivery of the high precision and high throughput equipment by several months.

“Catalent appreciates Stevanato Group’s commitment to delivering these vital inspection machines to our sites ahead of schedule,” says Dominick Marino, Vice President of Global Procurement at Catalent. “This added capability will increase the speed in which we package and supply important medicines for our customers and patients.”

“We understand what is at stake, and our engineers are committed to delivering high-performance inspection machines ahead of schedule to meet Catalent’s needs and expectations,” said Raffaele Pace, Engineering Vice President of Operations, Stevanato Group.